Nanologica AB (NICA) — Cash Flow-to-Debt Ratio
Nanologica AB (NICA) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of Skr-6.22 Million could theoretically repay 0% of its total liabilities (Skr164.82 Million) in one year. Check Nanologica AB (NICA) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanologica AB Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Nanologica AB across 11 annual periods. Also explore how large is Nanologica AB's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Nanologica AB (2015–2025)
Year-by-year debt coverage analysis for Nanologica AB. For market capitalisation and broader financial context, see Nanologica AB (NICA) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.61x | Skr-39.88 Million | Skr65.47 Million | ▲ +47.9% |
| 2024 | -1.17x | Skr-80.73 Million | Skr68.99 Million | ▼ -159.0% |
| 2023 | -0.45x | Skr-35.85 Million | Skr79.33 Million | ▲ +18.7% |
| 2022 | -0.56x | Skr-45.22 Million | Skr81.36 Million | ▲ +44.1% |
| 2021 | -1.00x | Skr-46.49 Million | Skr46.72 Million | ▼ -22.6% |
| 2020 | -0.81x | Skr-43.34 Million | Skr53.38 Million | ▼ -168.9% |
| 2019 | -0.30x | Skr-11.52 Million | Skr38.16 Million | ▲ +72.6% |
| 2018 | -1.10x | Skr-11.71 Million | Skr10.62 Million | ▼ -13.9% |
| 2017 | -0.97x | Skr-23.19 Million | Skr23.98 Million | ▲ +59.0% |
| 2016 | -2.36x | Skr-23.19 Million | Skr9.84 Million | ▼ -45.8% |
| 2015 | -1.62x | Skr-13.95 Million | Skr8.63 Million | — |